Insiders

Notable News Spotlight: Nektar Therapeutics (NASDAQ:NKTR)

On Dec. 17, 2019, Nektar Therapeutics (NASDAQ:NKTR) revealed it has appointed Myriam J. Curet, M.D., as an independent director to its Board of Directors. Dr. Curet brings three decades of experience working in the healthcare sector and academia, and currently serves as Executive Vice President and Chief Medical Officer for Intuitive Surgical, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.

Myriam is a veteran healthcare executive and trained surgeon with extensive experience overseeing clinical and regulatory affairs, said Howard W. Robin, President and Chief Executive Officer of Nektar Therapeutics. With her expertise in areas including market access, health economics and outcomes research, she will provide invaluable insights to our Board as we continue to advance our diverse portfolio of immuno-oncology and immunology programs.

Dr. Curet joined Intuitive Surgical in 2005 and has held a number of leadership positions of increasing responsibility. Previously, she served as Chief Medical Advisor and Senior Vice President, Chief Medical Officer. Since 2000, she has also held a faculty position at Stanford University School of Medicine, serving as a Clinical Professor of Surgery with a part-time clinical appointment at the Veteran’s Administration Medical Center in Palo Alto, California. Prior to joining Stanford, she served as Associate Professor of Surgery at the University of New Mexico. Earlier, she held various positions at the Indian Health Service, an agency within the Department of Health and Human Services (HHS). Dr. Curet began her career in medicine at the Gallup Indian Medical Center in New Mexico, where she was Medical Deputy Director.

On Tuesday Nektar Therapeutics (NASDAQ:NKTR) stock traded volume of 1783513 shares during its last trading session as compared to its average volume of 2891705 shares over the recent month. NKTR ended its day with the positive stream along the move of 2.63% and closed at the price of $21.47 before opening at $20.85. It has total market capitalization is $3777047366. 52week range of the stock remained $ 15.64 – 47.11 while its day lowest price was $20.6 and its hit its day highest price at $21.53.

Leave a Reply

Your email address will not be published. Required fields are marked *